Anika Therapeutics (ANIK) Other financing activities (2010 - 2025)
Anika Therapeutics (ANIK) posted quarterly Other financing activities of $239000.0 for Q4 2025, down 19.53% year-over-year from $297000.0 in Q4 2024, and down 8.43% quarter-over-quarter from $261000.0 in Q2 2025.
Anika Therapeutics (ANIK) Other financing activities (2010 - 2025) Analysis & Trends
Anika Therapeutics (ANIK) has reported Other financing activities for 16 consecutive years, with $239000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Other financing activities fell 19.53% year-over-year to $239000.0; the TTM figure through Dec 2025 stood at $500000.0 (down 29.38% YoY), while the FY2025 annual figure was $500000.0, down 29.38% from the prior year.
- Other financing activities slipped to $239000.0 in Q4 2025 per ANIK's latest filing, from $261000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $650000.0 in Q4 2022 and bottomed at $7000.0 in Q1 2023.
- Historically, Other financing activities has averaged $292769.2 across 5 years, with a median of $297000.0 in 2024.
- Annual changes were most pronounced in 2021 — Other financing activities sank 92.17% — and 2022, when it soared 470.18%.
- Anika Therapeutics' Other financing activities stood at $114000.0 in 2021, then jumped by 470.18% to $650000.0 in 2022, then slumped by 46.31% to $349000.0 in 2023, then retreated by 14.9% to $297000.0 in 2024, then retreated by 19.53% to $239000.0 in 2025.
- Business Quant data shows ANIK's Other financing activities at $239000.0 in Q4 2025, $261000.0 in Q2 2025, and $297000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Anika Therapeutics | 286.73 Mn | 248.32 Mn | 21.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 239,000.00 |
| Dec 31, 2025 | 239,000.00 |
| Jun 30, 2025 | 261,000.00 |
| Jun 30, 2025 | 261,000.00 |
| Dec 31, 2024 | 297,000.00 |
| Dec 31, 2024 | 297,000.00 |
| Jun 30, 2024 | 388,000.00 |
| Jun 30, 2024 | 388,000.00 |
| Mar 31, 2024 | 23,000.00 |
| Mar 31, 2024 | 23,000.00 |
| Dec 31, 2023 | 349,000.00 |
| Dec 31, 2023 | 349,000.00 |
| Jun 30, 2023 | 449,000.00 |
| Jun 30, 2023 | 449,000.00 |
| Mar 31, 2023 | 7,000.00 |
| Mar 31, 2023 | 7,000.00 |
| Dec 31, 2022 | 650,000.00 |
| Dec 31, 2022 | 650,000.00 |
| Mar 31, 2022 | 15,000.00 |
| Mar 31, 2022 | 15,000.00 |